Tue, January 3, 2023

Raghuram Selvaraju Maintained (AVXL) at Strong Buy with Increased Target to $50 on, Jan 3rd, 2023

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Anavex Life Sciences Corp." (AVXL) at Strong Buy with Increased Target from $42 to $50 on, Jan 3rd, 2023.

Raghuram has made no other calls on AVXL in the last 4 months.



There is 1 other peer that has a rating on AVXL. Out of the 1 peers that are also analyzing AVXL, all agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Charles Duncan of "Cantor Fitzgerald" Downgraded from Buy to Hold and Decreased Target to $11 on, Tuesday, December 6th, 2022